#FOLFOX
Kudos to Frank A. Sinicrope, MD, of Mayo Clinic, for one of the Most Significant Alliance Manuscripts 2025-2026! "Atezolizumab Plus FOLFOX for Stage III Mismatch Repair Deficient Colon Cancer " in NEJM #AllianceFall26 #NCI #NCTN #ATOMIC
November 6, 2026 at 5:09 PM
Hi Mick,

Sympathies, I am on the same path.

Stage 4 Colon cancer 2022 then chemo & radiation followed by surgery colon & section 6 of liver then 12 doses Folfox now metastic colon cancer in lung currently considering experimental procedures with Moffit Cancer Specialists here in USA.

Chin up !
November 2, 2026 at 5:38 AM
NEXERA-303 is evaluating INCA33890 plus FOLFOX and bevacizumab vs chemotherapy and bevacizumab alone in previously untreated MSS mCRC. #crcsm #oncology

Read more ➡️: www.onclive.com/view/nexera-...
NEXERA-303 Trial Aims to Bring TGFβR2×PD-1 Bispecific Antibody INCA33890 Into First-Line MSS CRC | OncLive
NEXERA-303 is evaluating INCA33890 plus FOLFOX and bevacizumab vs chemotherapy and bevacizumab alone in previously untreated MSS mCRC.
www.onclive.com
October 31, 2026 at 6:19 PM
When my wife was treated for cancer three years ago, the oncologist told her they wouldn’t have been able to fifteen years prior. Thank God for FOLFOX.
October 26, 2026 at 2:41 PM
💜 Treatment Information Booklets 💜

Our booklets include information about:

- Gemcitabine, cisplatin and durvalumab
- FOLFOX
- Ivosidenib
- Pemigatinib
- Futibatinib

Download the booklets from our website:
https://ammf.org.uk/patient-resources/

For a hard copy email: info@ammf.org.uk.
October 25, 2026 at 10:30 AM
gary king runs a company, OpenScholar, that boasts its own proprietary AI to connect people with funding

worthington looks "fine" except he seems to have his name on a really wide array of article topics moreso than being a published "expert" on any singular subject
October 23, 2026 at 8:29 PM
📰 The @fda.gov granted fast track designation to the oral multi-KRAS inhibitor QTX3034 in combination with cetuximab with or without FOLFOX for the treatment of patients with KRAS G12D–mutated CRC. #crcsm #oncology

Read more ➡️: www.onclive.com/view/qtx3034...
QTX3034 Plus Cetuximab Receives FDA Fast Track Designation in KRAS G12D–Mutated CRC | OncLive
The designation covers QTX3034 plus cetuximab with or without FOLFOX; phase 1 data showed a 25% confirmed ORR with the doublet in CRC and PDAC.
www.onclive.com
October 20, 2026 at 4:14 PM
📍 Encorafenib bei Darmkrebs: Hinweis auf beträchtlichen Zusatznutzen

➡️ Wir haben untersucht, ob Encorafenib in Kombination mit den Wirkstoffen Cetuximab und einer Chemotherapie (FOLFOX) bei der Erstlinienbehandlung Erwachsener mit metastasiertem […]

[Original post on wisskomm.social]
October 15, 2026 at 8:46 AM
🧬 What could a PD-1/TGF-β bispecific add to an established mCRC regimen?

WATCH: Moh’d Khushman, MD, of @sitemancenter.bsky.social, discusses the rationale and design of the phase 3 INCA033890-303 trial.

www.onclive.com/view/dr-khus...
Dr Khushman on the Rationale for Investigating INCA33890 in MSS/pMMR mCRC | OncLive
Moh’d Khushman, MD, discusses the rationale for investigating INCA33890 plus FOLFOX/bevacizumab in the phase 3 setting in patients with MSS/pMMR mCRC.
www.onclive.com
September 29, 2026 at 12:04 AM
New research from Dr. Giorgio Caturegli at #ASTRO26 compares neoadjuvant FOLFOX vs. CROSS chemoradiation for esophageal adenocarcinoma. FOLFOX was associated with higher CRR, higher 5-year recurrence-free and overall survival in unadjusted analyses. @astro-org.bsky.social
September 27, 2026 at 8:36 PM
Mom's going in to get her chemotherapy port installed tomorrow at 6 AM. She's getting FOLFOX 6 chemo, starting sometime in October, every two weeks, for six months. There's some sort of take-home thing involved, so she just goes in to get it started, and the device administers it.
September 21, 2026 at 12:54 AM
5-Fluorouracil-based chemotherapy disrupts autophagy flux and protein synthesis in cultured myotubes: a role for mTORC1 signaling
journals.physiology.org/doi/abs/10.1...
5-Fluorouracil-based chemotherapy disrupts autophagy flux and protein synthesis in cultured myotubes: a role for mTORC1 signaling | American Journal of Physiology-Cell Physiology | American Physiologi...
5-Fluorouracil-based chemotherapies, such as FOLFOX (5-fluorouracil, leucovorin, oxaliplatin), are used to treat colon cancer but also induce skeletal muscle toxicities. While FOLFOX can disrupt muscl...
journals.physiology.org
September 15, 2026 at 2:25 AM
Una piccola Marghe che urla al cielo perché N. mi possa sentire. 1985
music.youtube.com/watch?v=-aVx...
Afterhours - Grande (folfiri o folfox)
YouTube video by ASPARAGIONE
music.youtube.com
September 6, 2026 at 10:17 AM
If this man is diagnosed with colon cancer and his chemo doctor prescribes FOLFOX ($12,000 / month) gym bro might say "That's just big pharma again! Don't pay that! Just hold these crystals under your arms, and get some sunlight on your private parts!🤡" The man might believe it.😢
September 5, 2026 at 10:49 PM
News From Industry
BREAKWATER Update in #ColorectalCancer
Source PR NewsWire

www.prnewswire.com/news-release...

Pierre Fabre announced European Commission approval of encorafenib plus cetuximab and FOLFOX as first-line treatment for adults with BRAFV600E-mutant metastatic colorectal cancer.
June 23, 2026 at 12:14 PM
FOLFOX?
December 24, 2025 at 1:15 PM
[chemo] apparently you can only do 12 cycles of folfox. i'm more than halfway through, so in a few months we'll have to stop.

i guess after that we try a 3rd regimen, which may not work, like the 1st one we did. i'm not looking forward to losing more precious time on ineffective treatments
March 20, 2025 at 1:16 PM
3rd cycle of folfox isn't as rough as the first 2, thank goodness. 😮‍💨 & the oncologist says i'm due for another scan midway through next month to see if the chemo is working this time 🤞
January 15, 2025 at 4:04 PM
folfox used CHEMO! it was very effective
December 17, 2024 at 8:46 PM
actually yeah that's it! the last regimen was folfiri, this new one is folfox (the ox refers to oxaliplatin). thank you for jogging my memory, literally never would have figured it out
December 17, 2024 at 8:35 PM
TNT with short-course radiotherapy followed by CAPOX/FOLFOX achieved excellent long-term local and distant control in high-risk rectal cancer, with particularly favourable outcomes in patients achieving complete response
May 1, 2026 at 7:40 AM